Akishi Ooi

3.8k citations
86 papers · 3.0k indexed · h-index 32
Topics
HER2/EGFR in Cancer Research (14 papers)Monoclonal and Polyclonal Antibodies Research (13 papers)Cancer-related gene regulation (12 papers)
Journals
SHILAP Revista de lepidopterologíaPLoS ONECancer

In The Last Decade

Akishi Ooi

84 papers receiving 3.0k citations

Peers

Akishi Ooi
Comparison fields: 5 of 103
  • Oncology 1.6k
  • Pulmonary and Respiratory Medicine 1.1k
  • Molecular Biology 1.1k
  • Surgery 778
  • Cancer Research 482
Replace H. Nekarda with:
H. Nekarda Germany
Takushi Monden Japan
Akiko Kunita Japan
An Na Seo South Korea
Yasuyuki Fukai Japan
Jill Lacy United States
Yoshinari Ogawa Japan
Jin Hee Sohn South Korea
Yasushi Kasai Japan
T Kabuto Japan
Akishi Ooi relative to H. Nekarda Germany H. Nekarda's profile →
Citations per field
00.5×1.5×2.4×
H. Nekarda · 1×
Citations per year

Countries citing papers authored by Akishi Ooi

Since Specialization
Citations

This map shows the geographic impact of Akishi Ooi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akishi Ooi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akishi Ooi more than expected).

Fields of papers citing papers by Akishi Ooi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akishi Ooi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akishi Ooi. The network helps show where Akishi Ooi may publish in the future.

Co-authorship network of co-authors of Akishi Ooi

This figure shows the co-authorship network connecting the top 25 collaborators of Akishi Ooi. A scholar is included among the top collaborators of Akishi Ooi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akishi Ooi. Akishi Ooi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 4
3 9
4 21
5 2
6 9
7 14
8 26
9 18
10 5
11
Gene amplification of Myc and its coamplification with ERBB2 and EGFR in gallbladder adenocarcinoma.
26
12 28
13 117
14 250
15 43
16 64
17 173
18 1
19 8
20 11

About Akishi Ooi

Akishi Ooi is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 86 papers that have together received 3.0k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (14 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and Cancer-related gene regulation (12 papers). The work is most often cited by research in Oncology (1.6k citations), Pulmonary and Respiratory Medicine (1.1k citations) and Cancer Research (482 citations). Akishi Ooi has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Yoh Dobashi, Shioto Suzuki, Koji Kono, Mitsuhiko Hanawa, Tetsu Yamane, Isao Nakanishi, Kazuyoshi Kunitomo, Takuo Takehana, Yasuhisa Takeda and Hideki Fujii. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026